Holen Sie sich die Stockscreener-App
1.12
0.00%
0.00
Vorhandelsmarkt:
1.11
-0.01
-0.89%
Longeveron Inc Aktie (LGVN) Neueste Nachrichten
Longeveron Restores Executive Pay After Recent Financing - TipRanks
LGVN Stock Price, Quote & Chart | LONGEVERON INC-A (NASDAQ:LGVN) - ChartMill
Longeveron Inc. Files Form 8-K Current Report with SEC – Company Details and Stock Information (2026) - Minichart
Aug Setups: Is Longeveron Inc stock a value trapMarket Growth Summary & Safe Capital Allocation Plans - baoquankhu1.vn
Longeveron restores executive pay, approves new stock unit grants following financing By Investing.com - Investing.com South Africa
Longeveron restores executive pay, approves new stock unit grants following financing - Investing.com
Longeveron IncRepaid Executives For Compensation Reductions Following FinancingSEC Filing - TradingView — Track All Markets
Longeveron grants RSUs to executives after restoring reduced pay - TradingView — Track All Markets
Longeveron (NASDAQ: LGVN) restores pay and grants RSUs after financing - Stock Titan
Longeveron Prospectus Filed For Resale Of Up To 30.9 Million Class A Common Shares By Selling Stockholders- SEC Filing - TradingView — Track All Markets
Longeveron (NASDAQ: LGVN) resale filing details 30.9M registered shares - Stock Titan
Biotechs Racing to Translate Longevity Science Into Real Therapies — And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells - Cantech Letter
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells - Benzinga
IPO Launch: What is Longeveron Incs book value per share2026 Earnings Impact & Weekly Chart Analysis and Guides - baoquankhu1.vn
Longeveron receives China patent for stem cell potency assay By Investing.com - Investing.com Canada
Longeveron receives China patent for stem cell potency assay - Investing.com
Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs) - The Manila Times
China grants Longeveron stem cell patent rights running through 2041 - Stock Titan
Risk Check: Is Longeveron Inc stock good for income investors2026 Summary & Verified Short-Term Plans - baoquankhu1.vn
Market Outlook: Whats Longeveron Incs historical return2026 Opening Moves & Weekly High Return Opportunities - baoquankhu1.vn
Investment Review: Is Longeveron Inc exposed to currency risksEarnings Trend Report & Step-by-Step Trade Execution Guides - baoquankhu1.vn
LGVN Technical Analysis & Stock Price Forecast - Intellectia AI
[Form 4] Longeveron Inc. Insider Trading Activity - Stock Titan
Longeveron (LGVN) CMO has shares withheld to cover RSU tax obligations - Stock Titan
Longeveron (LGVN) CFO has 13,145 shares withheld to cover RSU tax - Stock Titan
Longeveron (LGVN) CEO has shares withheld to cover RSU tax bill - Stock Titan
Longeveron (NASDAQ: LGVN) CTO reports RSU tax-withholding of 8,633 shares - Stock Titan
Patterns Watch: Can Longeveron Inc outperform in the next rallyEarnings Recap Summary & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
LGVN Stock Chart | LONGEVERON INC-A (NASDAQ:LGVN) - ChartMill
LGVN: Laromestrocel shows strong clinical progress and regulatory momentum across multiple indications - TradingView
Movement Recap: How cyclical is Longeveron Incs revenue stream2026 PreEarnings & Entry and Exit Point Strategies - baoquankhu1.vn
Is Longeveron Inc stock good for income investorsTrade Entry Summary & Target Return Focused Picks - baoquankhu1.vn
Moving Averages: Will Longeveron Inc stock hit new highs in YEAR2026 Rallies & Step-by-Step Trade Execution Guides - baoquankhu1.vn
(LGVN.O) | Stock Price & Latest News - Reuters
Profit Review: Can Longeveron Inc outperform in the next rally2026 Major Catalysts & Reliable Price Breakout Alerts - baoquankhu1.vn
Longeveron Receives Extended Nasdaq Compliance Grace Period - tipranks.com
Longeveron Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView — Track All Markets
Longeveron (NASDAQ: LGVN) granted more time to cure Nasdaq $1 bid rule - Stock Titan
Longeveron braces for Q4 results following recent funding boost - MSN
Longeveron Cancels Special Meeting, Reschedules Reverse Split Vote - TipRanks
Longeveron (NASDAQ: LGVN) shifts reverse split proposal to annual - Stock Titan
Longeveron Inc. (NASDAQ:LGVN) Q4 2025 earnings call transcript - MSN
Longeveron launches offering of up to 11.8M shares via warrants and stock units - MSN
Longeveron secures $15M financing with potential for additional $15M tied to trial milestones - MSN
If You Invested $1,000 in Longeveron Inc (LGVN) - Stock Titan
Returns Recap: What are Eureka Acquisition Corps earnings expectationsMarket Trend Report & Safe Entry Point Identification - baoquankhu1.vn
Aug Action: What is Longeveron Incs revenue forecastTrade Volume Report & Weekly Breakout Stock Alerts - baoquankhu1.vn
Experience real-time quotes, in-depth charts, and analyst ratings - webull.com
Longeveron Inc. (NASDAQ:LGVN) Q4 2025 Earnings Call Transcript - Insider Monkey
Longeveron's third-quarter 2026 HLHS trial outcomes may confirm the viability of its overall business approach—while its Alzheimer's program continues to divert focus - Bitget
Longeveron’s Alzheimer’s Program Faces High Late-Stage Failure Risk and Potential Pipeline Pressure - TipRanks
Longeveron (LGVN) shares surge on $30 million private placement deal - MSN
Longeveron Earnings Call: Pivotal Trials, Tight Cash - TipRanks
Insider Buy: Will Longeveron Inc benefit from rising consumer demand2026 Trading Volume Trends & Growth Oriented Trading Recommendations - baoquankhu1.vn
Treasury Yields: Is Longeveron Inc stock a value trap2026 Rallies & Risk Controlled Daily Plans - baoquankhu1.vn
LGVN shares rise after investigational therapy shows improvement in age-related frailty in study - MSN
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):